journal article·2019-03Open access

Fabrication of a nanoparticle-containing 3D porous bone scaffold with proangiogenic and antibacterial properties

Juan L. Paris, Nuria Lafuente-Gómez, M. Victoria Cabañas, Jesús Román, Juan Peña, María Vallet-Regí

Acta Biomaterialia· Volume 86

Abstract

3D porous scaffolds based on agarose and nanocrystalline apatite, two structural components that act as a temporary mineralized extracellular matrix, were prepared by the GELPOR3D method. This shaping technology allows the introduction of thermally-labile molecules within the scaffolds during the fabrication procedure. An angiogenic protein, Vascular Endothelial Growth Factor, and an antibiotic, cephalexin, loaded in mesoporous silica nanoparticles, were included to design multifunctional scaffolds for bone reconstruction. The dual release of both molecules showed a marked increase in the number of blood vessels on embryonic day 14 in chicken embryos grown ex ovo, while, at the same time providing an antibiotic local concentration capable of inhibiting Staphylococcus aureus bacterial growth. In this sense, different release patterns, monitored by UV-spectroscopy, could be tailored as a function of the cephalexin loading strategy, either releasing all the loaded cephalexin in the first 4 h or less than 50% after 24 h. The scaffold surface was characterized by a high hydrophilicity, with contact angles between 50° and 63°, which enabled the adhesion and proliferation of preosteoblastic cells. STATEMENT OF SIGNIFICANCE: The localized delivery of bioactive molecules has attracted significant attention due to the potential for dose reduction as well as reduced side effects compared to systemic delivery. In this article multifunctional 3D porous scaffolds with a designed porosity have been fabricated. The method also enables the controlled loading of an antibiotic drug and an angiogenic protein into the scaffold. These scaffolds, whose composition resembles the extracellular matrix are suitable for the adhesion of preosteoblast cells, exhibit a sustained cephalexin delivery adequate for inhibiting bacterial growth as well as release the proangiogenic molecule which induces blood vessel formation in chicken embryos grown ex ovo.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Orthopedic Infections and Treatments · Orthopaedic implants and arthroplasty

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (68)

Show source-provided references
1. Critical reviews in oral biology & medicine: aging and bone10.1177/0022034510377791 ↗
2. Effect of age on biomaterial-mediated in situ bone tissue regeneration10.1016/j.actbio.2018.06.035 ↗
3. Effect of aging on fracture healing
4. Healthcare use among U.S. women aged 45 and older: total costs and costs for selected postmenopausal health risks10.1089/jwh.1.1999.8.1077 ↗
5. The relevance of biomaterials to the prevention and treatment of osteoporosis10.1016/j.actbio.2014.01.004 ↗
6. Musculoskeletal disorders and the Global Burden of Disease study10.1136/annrheumdis-2014-205327 ↗
7. Prevalence of total hip and knee replacement in the United States10.2106/JBJS.N.01141 ↗
8. Porous composite scaffold incorporating osteogenic phytomolecule icariin for promoting skeletal regeneration in challenging osteonecrotic bone in rabbits10.1016/j.biomaterials.2017.10.025 ↗
9. Micro and nanotechnologies for bone regeneration: recent advances and emerging designs10.1016/j.jconrel.2018.01.032 ↗
10. Biomimetic approaches for Bone tissue engineering10.1089/ten.teb.2016.0289 ↗
11. Designing biomimetic scaffolds for bone regeneration: why aim for a copy of mature tissue properties if nature uses a different approach?10.1039/c0sm00262c ↗
12. Bone tissue engineering via growth factor delivery: from scaffolds to complex matrices
13. Biomimetic approaches in bone tissue engineering: Integrating biological and physicomechanical strategies10.1016/j.addr.2014.09.005 ↗
14. Review: development of clinically relevant scaffolds for vascularised bone tissue engineering10.1016/j.biotechadv.2012.10.003 ↗
15. 3D bioprinting for biomedical devices and tissue engineering: a review of recent trends and advances
16. Effects of bone substitute architecture and surface properties on cell response, angiogenesis, and structure of new bone10.1039/C7TB00741H ↗
17. Fabrication of 3D porous poly(lactic acid)-based composite scaffolds with tunable biodegradation for bone tissue engineering10.1016/j.matdes.2018.01.016 ↗
18. Nanocolumnar coatings with selective behavior towards osteoblast and Staphylococcus aureus proliferation10.1016/j.actbio.2014.12.023 ↗
19. Fabrication of novel Si-doped hydroxyapatite/gelatine scaffolds by rapid prototyping for drug delivery and bone regeneration10.1016/j.actbio.2014.12.021 ↗
20. In vitro colonization of stratified bioactive scaffolds by pre-osteoblast cells10.1016/j.actbio.2016.08.014 ↗
21. Topological design and additive manufacturing of porous metals for bone scaffolds and orthopaedic implants: a review10.1016/j.biomaterials.2016.01.012 ↗
22. Importance of dual delivery systems for bone tissue engineering10.1016/j.jconrel.2016.01.033 ↗
23. Dual-controlled release system of drugs for bone regeneration10.1016/j.addr.2015.06.003 ↗
24. Advancements and challenges in multidomain multicargo delivery vehicles10.1002/adma.201704324 ↗
25. Delivery of VEGFA in bone marrow stromal cells seeded in copolymer scaffold enhances angiogenesis, but is inadequate for osteogenesis as compared with the dual delivery of VEGFA and BMP2 in a subcutaneous mouse model10.1186/s13287-018-0778-4 ↗
26. Tissue engineering strategies for promoting vascularized bone regeneration10.1016/j.bone.2015.11.011 ↗
27. Infection associated with prosthetic joints10.1056/NEJMcp0905029 ↗
28. Composite chitosan and calcium sulfate scaffold for dual delivery of vancomycin and recombinant human bone morphogenetic protein-210.1007/s10856-014-5167-7 ↗
29. Design of calcium phosphate ceramics for drug delivery applications in bone diseases: a review of the parameters affecting the loading and release of the therapeutic substance10.1016/j.jconrel.2017.02.012 ↗
30. Multifunctional pH sensitive 3D scaffolds for treatment and prevention of bone infection10.1016/j.actbio.2017.11.009 ↗
31. Bone tissue engineering drug delivery10.1007/s40610-015-0016-0 ↗
32. Hierarchically macroporous/mesoporous POC composite scaffolds with IBU-loaded hollow SiO2 microspheres for repairing infected bone defects10.1039/C6TB00435K ↗
33. Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds10.1098/rsif.2009.0379 ↗
34. Nanoparticles for imaging, sensing, and therapeutic intervention10.1021/nn500962q ↗
35. Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration10.2147/IJN.S44393 ↗
36. Current applications of nanoparticles in infectious diseases10.1016/j.jconrel.2016.01.008 ↗
37. Combinatorial delivery of bioactive molecules by a nanoparticle-decorated and functionalized biodegradable scaffold10.1039/C8TB00474A ↗
38. Preparation of dexamethasone-loaded biphasic calcium phosphate nanoparticles/collagen porous composite scaffolds for bone tissue engineering10.1016/j.actbio.2017.12.004 ↗
39. Mesoporous silicate nanoparticles/3D nanofibrous scaffold-mediated dual-drug delivery for bone tissue engineering10.1016/j.jconrel.2018.04.011 ↗
40. Mesoporous silica nanoparticles for drug delivery: current insights
41. Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery10.1021/cm402592t ↗
42. Controlled growth of monodispersed silica spheres in the micron size range10.1016/0021-9797(68)90272-5 ↗
43. Polymer-grafted mesoporous silica nanoparticles as ultrasound-responsive drug carriers10.1021/acsnano.5b04378 ↗
44. A new property of MCM-41: drug delivery system10.1021/cm0011559 ↗
45. Preparation of cefalexin/MCM-41 composite material and its controlled release property10.14233/ajchem.2013.14055 ↗
46. High specific surface area in nanometric carbonated hydroxyapatite10.1021/cm801626k ↗
47. Controlled crystallization of calcium phosphate apatites10.1021/cm001033g ↗
48. An alternative technique to shape scaffolds with hierarchical porosity at physiological temperature10.1016/j.actbio.2009.10.049 ↗
49. Control of the pore architecture in three-dimensional hydroxyapatite-reinforced hydrogel scaffolds10.1088/1468-6996/12/4/045003 ↗
50. Tuning dual-drug release from composite scaffolds for bone regeneration10.1016/j.ijpharm.2015.03.048 ↗
51. The soluble form of a disintegrin and metalloprotease 33 promotes angiogenesis: implications for airway remodeling in asthma10.1016/j.jaci.2008.03.003 ↗
52. Human peripheral blood eosinophils induce angiogenesis10.1016/j.biocel.2004.09.001 ↗
53. In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF10.1096/fj.01-0633fje ↗
54. Calcium sulphate-based cements containing cephalexin10.1016/j.biomaterials.2003.09.037 ↗
55. Multiple applications of alamar blue as an indicator of metabolic function and cellular health in cell viability bioassays10.3390/s120912347 ↗
56. Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles10.1038/nprot.2010.103 ↗
57. Controlled release of antimicrobial Cephalexin drug from silica microparticles10.1016/j.msec.2013.10.002 ↗
58. Hydrogels in pharmaceutical formulations10.1016/S0939-6411(00)00090-4 ↗
59. Modeling and comparison of dissolution profiles10.1016/S0928-0987(01)00095-1 ↗
60. Calcium phosphates as substitution of bone tissues10.1016/j.progsolidstchem.2004.07.001 ↗
61. Agarose-based biomaterials for tissue engineering10.1016/j.carbpol.2018.01.060 ↗
62. Tailoring vancomycin release from β-TCP/agarose scaffolds10.1016/j.ejps.2009.02.011 ↗
63. Design of tunable protein-releasing nanoapatite/hydrogel scaffolds for hard tissue engineering10.1016/j.matchemphys.2014.01.011 ↗
64. Improved connective integration of a degradable 3D-nano-apatite/agarose scaffold subcutaneously implanted in a rat model10.1177/0885328218810084 ↗
65. In vitro characterization of 3D printed scaffolds aimed at bone tissue regeneration10.1016/j.colsurfb.2018.02.038 ↗
66. Functionalization degree of SBA-15 as key factor to modulate sodium alendronate dosage10.1016/j.micromeso.2008.03.025 ↗
67. Angiogenesis in bone regeneration10.1016/j.injury.2011.03.035 ↗
68. VEGF-activated angiogenesis during bone regeneration10.1016/j.joms.2005.05.303 ↗